Danaher easily beats the consensus











Photo credit © PivèsPictures


(Boursier.com) — Danaher , the American conglomerate, a scientific and technological innovator on a global scale, published for its fourth fiscal quarter ended at the end of December, a net profit of 2.2 billion dollars and 2.99$ per share, an increase of 25% in year-on-year. Adjusted earnings per share represented $2.87, up 6.5%. Revenue rose 2.5% to $8.4 billion. The consensus was $2.51 adjusted EPS.

Starting in the first quarter of 2023, the company will revise its definition of core business growth to exclude revenue related to Covid-19 testing, vaccines and therapeutics, in addition to excluding currency translation. , acquisitions and divested product lines. For the first quarter of 2023, Danaher expects non-GAAP core revenue growth to be mid-single digit, around 5%. For the full year 2023, the company expects non-GAAP core revenue to be up mid-single digit, 6-9%.


©2023 Boursier.com






Source link -87